| 2005 |
WNK1 and WNK4 phosphorylate OSR1 at two sites: Thr185 in the T-loop of the catalytic domain and Ser325 in the C-terminal non-catalytic region. Phosphorylation of Thr185 is required for OSR1 activation; mutation to Ala abolishes activation by WNK1, while mutation to Glu (phosphomimetic) increases basal activity >20-fold. Mutation of Ser325 does not affect OSR1 activity. |
In vitro phosphorylation assay, phosphopeptide mapping, site-directed mutagenesis (T185A, T185E, S325A, S325E), kinase activity assays |
The Biochemical journal |
High |
16083423
|
| 2002 |
OSR1 physically interacts with cation-chloride cotransporters NKCC1, NKCC2, and KCC3 (but not KCC1 or KCC4) via the last ~100 amino acids of OSR1. The binding motif on the cotransporters begins with an (R/K)FX(V/I) sequence. Interaction was established by yeast two-hybrid and GST pull-down. |
Yeast two-hybrid, GST pull-down, co-immunoprecipitation from mouse brain |
The Journal of biological chemistry |
High |
12386165
|
| 2006 |
OSR1 directly phosphorylates NKCC1 at three conserved residues (Thr203/Thr207/Thr212 in human NKCC1). A 92-residue conserved C-terminal (CCT) domain on OSR1 interacts with an RFXV motif present in both its activators (WNK1/WNK4) and substrate (NKCC1); mutation of the CCT domain inhibits NKCC1 phosphorylation. An intact CCT domain is required for efficient WNK1-mediated phosphorylation and activation of OSR1. |
In vitro kinase assay, peptide substrate development (CATCHtide), mutagenesis of CCT domain, affinity purification |
The Biochemical journal |
High |
16669787
|
| 2007 |
Crystal structure of the OSR1 CCT domain in complex with a WNK4-derived RFXV peptide was solved at 2.25 Å. The CCT domain forms a novel protein fold with a surface-exposed groove that engages the Arg-Phe-Xaa-Val motif. Phosphorylation of a Ser/Thr residue preceding the RFXV motif causes steric clash, promoting dissociation from the CCT domain. Mutational analysis confirmed that these interactions are required for binding to WNK1 and NKCC1. |
X-ray crystallography, mutational analysis, binding assays |
EMBO reports |
High |
17721439
|
| 2009 |
Crystal structure of the OSR1 kinase domain was solved at 2.25 Å, revealing a domain-swapped dimer in an inactive conformation in which the P+1 loop and αEF helix are swapped between dimer-related monomers. |
X-ray crystallography |
Protein science |
High |
19177573
|
| 2006 |
WNK1 regulates OSR1 activity in cells: OSR1 exists in a complex with WNK1 in HeLa cells, is activated by recombinant WNK1 in vitro, and is phosphorylated in a WNK1-dependent manner in cells. siRNA depletion of WNK1 reduces OSR1 kinase activity. Depletion of OSR1 reduces NKCC activity, establishing that both WNK1 and OSR1 are required for NKCC function in volume regulation. |
Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, NKCC activity assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16832045
|
| 2005 |
WNK1 phosphorylates OSR1 at a conserved serine residue outside the kinase domain; mutation of this serine causes enhanced OSR1 kinase activity. SPAK and OSR1 directly phosphorylate the N-terminal regulatory regions of NKCC1, NKCC2, and NCC. Phosphorylation of NCC is induced by hypotonic stress. |
In vitro kinase assay, mutational analysis, cell-based phosphorylation assays |
The Journal of biological chemistry |
High |
16263722
|
| 2008 |
SPAK and OSR1 (activated by WNK1) phosphorylate human NCC at Thr46, Thr55, and Thr60. Efficient phosphorylation requires a docking interaction between an RFXI motif in NCC and SPAK/OSR1. Mutation of Thr60 to Ala markedly inhibits phosphorylation of Thr46 and Thr55 and abolishes NCC activation by hypotonic low-chloride treatment. |
In vitro kinase assay, mutagenesis, cell-based phosphorylation assays in HEK293 and mpkDCT cells |
Journal of cell science |
High |
18270262
|
| 2011 |
MO25α and MO25β bind to OSR1 and induce ~100-fold activation of OSR1, dramatically enhancing its ability to phosphorylate NKCC1, NKCC2, and NCC. siRNA-mediated reduction of MO25 isoforms in mammalian cells inhibited phosphorylation of endogenous NKCC1 at SPAK/OSR1-dependent sites, which was rescued by re-expression of MO25α. |
In vitro kinase assay, co-immunoprecipitation, siRNA knockdown with rescue, phospho-specific immunoblot |
The EMBO journal |
High |
21423148
|
| 2014 |
WNK-activated SPAK/OSR1 directly phosphorylates all KCC isoforms at a conserved C-terminal threonine (Site-2, Thr1048 in KCC3A) in vitro, inhibiting KCC activity. In ES cells lacking SPAK/OSR1 activity, KCC Site-2 phosphorylation is abolished and KCC3A activity is elevated. A KCC3A Site-2 alanine mutant shows increased activity, confirming SPAK/OSR1-mediated inhibition. |
In vitro phosphorylation assay with MO25, SPAK/OSR1 knockout ES cells, 86Rb+ flux assay, WNK pathway inhibitor (STOCK1S-50699), mutagenesis |
The Biochemical journal |
High |
24393035
|
| 2012 |
OSR1 (with SPAK) directly phosphorylates NKCC2 at Thr95, Thr100, Thr105 (and possibly Ser91) via interaction with an RFQV motif on NKCC2. Unlike NCC, NKCC2 membrane localization is constitutive and not triggered by SPAK/OSR1 phosphorylation. |
In vitro kinase assay, mutagenesis, cell-based phosphorylation, functional NKCC2 activity measurements |
Journal of cell science |
High |
21321328
|
| 2012 |
In double-knockin ES cells where SPAK and OSR1 cannot be activated by WNK1 (T-loop mutations), NKCC1 is not phosphorylated or activated, providing genetic proof that SPAK/OSR1 activity is essential for WNK1-mediated NKCC1 regulation. Additionally, SPAK/OSR1 activity significantly suppresses WNK1 and WNK3 activity (negative feedback). |
Double-knockin ES cells (SPAK and OSR1 T-loop alanine mutations), phospho-specific immunoblot, kinase assay |
The Biochemical journal |
High |
22032326
|
| 2011 |
NCC phosphorylation in vivo is almost completely abolished in Wnk4(D561A/+) mice crossed with SPAK and OSR1 T-loop knockin mice (T243A and T185A), demonstrating that in vivo NCC phosphorylation is entirely dependent on the WNK-OSR1/SPAK cascade. High blood pressure, hyperkalemia, and metabolic acidosis observed in Wnk4(D561A/+) mice were corrected in triple knockin mice. |
Triple-knockin mouse model, phospho-specific immunoblot, blood pressure measurement, metabolic analysis |
Journal of cell science |
High |
21486947
|
| 2004 |
OSR1 is activated selectively by osmotic stresses (sorbitol, NaCl) in mammalian cells. OSR1 phosphorylates threonine 84 in the N-terminal regulatory domain of PAK1; replacement of Thr84 with Glu reduces PAK1 activation by Cdc42, suggesting OSR1 modulates G-protein sensitivity of PAK isoforms. |
Kinase activity assays, yeast two-hybrid, in vitro phosphorylation, mutagenesis |
The Journal of biological chemistry |
Medium |
14707132
|
| 2005 |
OSR1 phosphorylates RELT family members (RELT, RELL1, RELL2) in an in vitro kinase assay. OSR1 was identified as an interactor of RELL1 via yeast two-hybrid screen and shown to interact with all three RELT family members by co-immunoprecipitation. |
Yeast two-hybrid, co-immunoprecipitation, in vitro kinase assay |
Biochemical and biophysical research communications |
Medium |
16389068
|
| 2013 |
mTORC2 phosphorylates OSR1 on Ser339 in vitro, and inhibition of PI3K or depletion of Sin1 (an mTORC2 component) decreases OSR1 activation by osmotic stress and reduces NKCC activity. Mutation of Ser339 eliminates mTORC2-mediated phosphorylation of OSR1. |
In vitro kinase assay, siRNA depletion, pharmacological inhibition, mutagenesis, NKCC activity assay |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
24191005
|
| 2013 |
Global and endothelial-specific deletion of Osr1 in mice causes embryonic lethality with angiogenesis and cardiac defects identical to WNK1 knockout. Endothelial-specific expression of a constitutively active OSR1 transgene rescues angiogenesis and cardiac defects in global WNK1-null embryos, establishing OSR1 as an essential downstream effector of WNK1 in embryonic cardiovascular development. |
Conditional knockout mice (Osr1 flox/Tie2-Cre), constitutively active OSR1 transgenic rescue, embryo phenotyping |
The Journal of biological chemistry |
High |
23386621
|
| 2014 |
In endothelial cells, WNK1-OSR1 signaling is required for HUVEC chemotaxis and invasion, while SPAK mediates endothelial cell proliferation. Knockdown experiments in HUVECs showed OSR1 (not SPAK) is required for cord formation and chemotaxis. OSR1 KO embryos can be rescued by constitutively active OSR1 in endothelium, separating OSR1 and SPAK functions. |
siRNA knockdown, cord formation assay, chemotaxis/invasion assay, endothelial-specific conditional knockout |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
25362046
|
| 2012 |
In SPAK-null mice, OSR1 becomes largely inactive, displaced from MO25α and NCC at the apical membrane of the distal convoluted tubule, and redistributes to dense punctate structures containing WNK1 in the cytoplasm. OSR1 in the DCT depends on SPAK for its proper localization and activity, demonstrating that SPAK and OSR1 act in a nephron-segment-specific manner with interdependence. |
SPAK knockout mouse model, immunofluorescence, subcellular fractionation, phospho-specific immunoblot |
The Journal of biological chemistry |
Medium |
22977235
|
| 2012 |
OSR1 coexpression in Xenopus oocytes significantly upregulates phosphate-induced currents via NaPiIIa (the major renal tubular phosphate transporter). In osr1tg/(+) knockin mice (carrying a WNK-resistant OSR1 allele), urinary phosphate excretion is increased and NaPiIIa abundance in the brush border is reduced, suggesting OSR1 positively regulates renal phosphate transport. |
Xenopus oocyte co-expression with voltage clamp, knockin mouse model, immunohistochemistry |
Kidney & blood pressure research |
Medium |
23095210
|
| 2014 |
OSR1 activates inward rectifier K+ channels Kir2.1 and Kir2.3 via a variant binding motif (R-x-F-x-V/I) in these channels. Mutation of this motif in Kir2.3 prevents activation by OSR1. siRNA knockdown of OSR1 and WNK inhibition disrupt NaCl-induced plasma membrane localization of Kir2.3, suggesting OSR1 promotes channel activity by increasing plasma membrane localization. |
siRNA knockdown, WNK inhibitor treatment, mutagenesis of R-x-F-x-V motif, plasma membrane localization assay |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
29581290
|
| 2019 |
The E3 ubiquitin ligase complex Cullin4-DDB1-WDR3/WDR6 binds OSR1 in a manner dependent on phosphorylation of the S-motif (conserved serine in the WEWS motif). S-motif phosphorylation under osmotic stress abolishes this binding, and proteasomal/neddylation inhibitors show that OSR1 ubiquitylation is suppressed when the S-motif is phosphorylated. |
Affinity pull-down, mass spectrometry, proteasomal and neddylation inhibitors, phospho-mutant analysis |
Chembiochem |
Medium |
31614064
|
| 2018 |
C-terminal serine phosphorylation of OSR1 in the WEWS motif (S-motif), carried out by WNK kinases in vitro and in cells, enhances binding of MO25 to OSR1. Mutagenesis identified key MO25 residues required for MO25 binding and subsequent activation of OSR1. |
In vitro kinase assay, mutagenesis, co-immunoprecipitation/binding assays |
Biochemical and biophysical research communications |
Medium |
30060950
|
| 2020 |
OSR1 (as a kinase) directly phosphorylates the linker region of Smad2 at Thr220 and Smad3 at Thr179 in breast cancer cells. Phosphorylated Smad2/3 translocates to the nucleus to enhance TGF-β1 autocrine signaling and increase transcription of EMT regulators. OSR1 directly interacts with Smad2/3 as shown by co-immunoprecipitation. |
Co-immunoprecipitation, in vitro kinase assay, mutagenesis, reporter assays, loss-of-function with specific phenotypic readouts (EMT, metastasis in vitro and in vivo) |
Oncogene |
Medium |
33051597
|
| 2012 |
OSR1 phosphorylation in the kidney displays a circadian rhythm dependent on aldosterone; phosphorylation levels of OSR1 (and downstream SPAK and NCC) are elevated around the start of the active period. Eplerenone (aldosterone receptor blocker) attenuates OSR1 phosphorylation and diminishes the diurnal rhythm. |
Time-course immunoblotting in mouse kidneys, pharmacological blockade with eplerenone |
Biochemical and biophysical research communications |
Medium |
23044422
|
| 2008 |
Dietary salt regulates phosphorylation of OSR1 (and SPAK) and NCC through aldosterone. Low-salt diet increases OSR1/SPAK and NCC phosphorylation; high-salt decreases it. These effects are reversed by spironolactone or exogenous aldosterone administration, placing aldosterone upstream of the WNK-OSR1/SPAK-NCC cascade. |
Mouse dietary manipulation, spironolactone/aldosterone treatment, phospho-specific immunoblot |
Kidney international |
Medium |
18800028
|
| 2012 |
ASK3 interacts with WNK1 and suppresses the WNK1-SPAK/OSR1 signaling pathway in the kidney. Knockdown of Ask3 by siRNA enhances WNK1-SPAK/OSR1 activation; Ask3 knockout mice exhibit hyperactivation of SPAK/OSR1 in renal tubules and a hypertensive phenotype. |
Co-immunoprecipitation, siRNA knockdown, knockout mouse model, phospho-specific immunoblot, blood pressure measurement |
Nature communications |
Medium |
23250415
|
| 2012 |
The PI3K/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice. Increased NCC phosphorylation and blood pressure in db/db mice were completely corrected in compound knockin mice carrying the Osr1(T185A) mutation (preventing WNK-mediated OSR1 activation), demonstrating that OSR1 phosphorylation by WNK is required for NCC activation in this model. |
Knockin mouse model (Osr1T185A), PI3K/Akt inhibitors (NVP-BEZ235, GDC-0941, MK-2206), phospho-specific immunoblot, blood pressure measurement |
Hypertension |
High |
22949526
|
| 2016 |
SPAK/OSR1 double-knockout mice develop severe hypokalemia under dietary potassium restriction due to inability to phosphorylate NCC, whereas single knockouts maintain plasma K+. This establishes that SPAK and OSR1 together are essential effectors of the pathway by which the distal convoluted tubule senses plasma K+ and activates NCC. |
Double-knockout mouse model, dietary manipulation, plasma electrolyte measurements, phospho-specific immunoblot for NCC/NKCC2 |
The Journal of physiology |
High |
27068441
|
| 2016 |
SPAK and OSR1 kinases are packaged into exosomes and transported between cells. Exosomal OSR1 is preferentially localized at the plasma membrane after uptake and maintains NKCC1 in a phosphorylated state, demonstrating that exosome-delivered OSR1 is functionally active. |
Differential centrifugation exosome isolation, Western blot, immunogold electron microscopy, fluorescent protein tracking, phospho-NKCC1 immunoblot |
American journal of physiology. Cell physiology |
Low |
27122160
|
| 2014 |
OSR1 acts in the WNK1/OSR1/NKCC1 signaling pathway in glioma cells. siRNA knockdown of OSR1 abolishes NKCC1 regulatory phospho-activation, reduces intracellular K+ and Cl- content and regulatory volume increase, and significantly decreases glioma cell migration after temozolomide treatment. |
siRNA knockdown, cell volume measurement, ion content assays, chemotaxis assay, live cell imaging |
Molecular cancer |
Medium |
24555568
|
| 2014 |
In the developing kidney, Osr1 and Six2 act synergistically to prevent premature differentiation of cap mesenchyme nephron progenitors. Osr1, but not Six2, enhances TCF interaction with Groucho family transcriptional co-repressors, and loss of Osr1 results in β-catenin/TCF-mediated ectopic activation of a Wnt4 enhancer reporter. Osr1 protein forms complexes with TCF proteins. |
Tissue-specific conditional knockout, co-immunoprecipitation of Osr1-TCF-Groucho complexes, in vivo reporter gene assay |
Development (Cambridge, England) |
Medium |
24598167
|
| 2016 |
Osr1 interacts with Wt1 protein in the developing kidney as shown by CRISPR-tagged endogenous Osr1. Osr1+/-;Wt1+/- double heterozygous mice exhibit metanephric kidney agenesis/hypoplasia and reduced Pax2+/Six2+ nephron progenitor cells with decreased Gdnf expression, demonstrating synergistic genetic interaction. |
CRISPR-mediated endogenous protein tagging, co-immunoprecipitation, double-heterozygous mouse genetics, immunofluorescence, in situ hybridization |
PloS one |
Medium |
27442016
|
| 2012 |
In Xenopus, Osr1 and Osr2 repress Bmp4 expression in the lateral plate mesoderm, and this repression is required for Wnt2b/Wnt2b-mediated lung specification. FGF and RA signals are upstream activators of osr1/osr2 expression. Depletion of both Osr1 and Osr2 results in agenesis of lungs, trachea, and esophagus. |
Morpholino knockdown, in situ hybridization, epistasis analysis |
Development (Cambridge, England) |
Medium |
22791896
|
| 2022 |
In zebrafish, the HSN2 isoform of WNK1 phosphorylates and activates OSR1, which in turn regulates neurite outgrowth through GSK3β and LHX8 transcription factor induction. HSN2 mutations from HSANII patients suppress OSR1 activation and LHX8 induction, demonstrating a WNK1(HSN2)-OSR1/GSK3β-LHX8 pathway in neuronal differentiation. |
In vitro kinase assay, co-immunoprecipitation, dominant-negative/mutant expression, neurite outgrowth assay, LHX8 reporter assay |
Scientific reports |
Medium |
36151370
|